SYN321
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYN321, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis [Phase 1, Phase 2]